Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

RAN Biotechnologies Announces Distributorship Agreement with Fluigent

Published: Wednesday, July 16, 2014
Last Updated: Tuesday, July 15, 2014
Bookmark and Share
Agreement with Fluigent in France provides industry-leading solution for droplet microfluidic applications throughout EU region.

RAN Biotechnologies has entered into a distributorship  agreement with Fluigent  for distribution of RAN Biotechnologies products in Europe. 

“We are very excited to be distributing the products of RAN Biotechnologies,” said Dr. Jérémie Weber, CTO and co-founder of Fluigent. “Their chemicals and solutions are the state-of-the-art for droplet microfluidics. We believe the combination of RAN Biotechnologies reagents and our microfluidic instruments will lead to a very powerful platform for droplet microfluidic applications.”

Droplet microfluidics is an alternative technology for Lab-on-a-chip systems, where manipulation of discrete micro-droplets is performed. Such a technology is compatible with many chemicals and biologicals and allows the programmation of various digital fluidic operations. These valuable advantages have the potential to enhance biomedical research and secure a rapidly growing market share in diagnostics and therapeutics. 

“Our expertise in synthetic and surface chemistry in general and in surfactants in particular, allows us to develop advanced materials for microfluidics”, said Dr. Roger Nassar, founder and President of RAN Biotechnologies. Dr. Nassar added, “Partnering with Fluigent is a major step in our exposure efforts in Europe after winning the Young Entrepreneurs initiative (YEi’13) award, which is organized by the French Embassy in the United States and the French Innovation Network (Retis). It will help us to reach a wider microfluidic market and allow us to be part of important new technologies by advancing lab-on-a-chip applications.”

RAN Biotechnologies’ fluorosurfactants and microfluidic surface coatings stabilize water-in-oil emulsions for droplet microfluidics and can encapsulate biologicals, such as DNA, RNA, cells and proteins, permitting their study and interrogation. High-throughput single cell screening, DNA amplification and chemical reactions are some of the manipulations performed inside these unique droplets. 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!